For people currently searching for drug rehab or opioid treatment options, this legal closing marks a long-overdue moment of accountability in a crisis that has shaped the modern addiction treatment landscape.
What Happened in Court
A federal judge delivered a criminal sentence to Purdue Pharma on April 28, 2026, resolving a U.S. Department of Justice probe, the last legal step needed to clear the way for the broader settlement.
The sentencing, held in New Jersey federal court, followed Purdue’s 2020 guilty plea to charges of deceiving government regulators and paying kickbacks to doctors to boost OxyContin sales.
From 2007 through 2017, Purdue unlawfully promoted its opioid products to hundreds of prescribers it had reason to suspect were issuing prescriptions without a legitimate medical purpose, according to the Department of Justice.
The company previously pleaded guilty to misbranding and fraud charges in 2007, admitting it falsely marketed OxyContin as less addictive and less likely to cause withdrawal symptoms than competing pain medications.
The Scale of the Settlement
The financial reckoning is enormous. The guilty plea and civil settlement with the federal government included $8.3 billion in forfeitures, fines and penalties, though the federal government agreed to collect just $225 million in exchange for Purdue reaching a separate resolution of thousands of lawsuits from state, local and Native American tribal governments.
The broader settlement calls for members of the Sackler family, who own the company, to contribute up to $7 billion over 15 years, with most of the money directed to government entities to use in fighting the opioid crisis.
Overall, the settlements are worth more than $50 billion and most of the money is designated to address the overdose epidemic.
For context, this represents one of the largest pharmaceutical accountability settlements in U.S. history, and one with direct implications for how addiction treatment is funded nationwide.
What Victims Receive
For individuals and families directly harmed by OxyContin, the settlement offers limited but meaningful financial acknowledgment. Payments to individual victims are expected to range from about $8,000 to $16,000. Purdue’s guilty plea did not include restitution to victims.
As part of the Purdue agreement, Sackler family members will be protected from future opioid-related lawsuits brought by individuals who choose to accept the settlement payments.
That provision drew criticism from victim advocates during Tuesday’s hearing, with some requesting the judge reject the negotiated sentence.
Purdue Closes, a New Entity Opens
Purdue permanently ceased operations on May 1, 2026. Nearly all of Purdue’s assets have been transferred to a newly created company, Knoa Pharma LLC, which will carry on distributing the medications formerly sold under the Purdue name.
Purdue will be dissolved and replaced by a new organization dedicated to serving the public interest, as a sweeping legal settlement resolving thousands of lawsuits comes into force.
The transition is meant to redirect the company’s pharmaceutical infrastructure toward public health purposes such as harm reduction rather than profit.
What This Means for Treatment Seekers
The opioid crisis Purdue helped create generated enormous demand for drug rehab and addiction treatment, demand that outpaced available resources for years.
The $50 billion-plus in settlements, once distributed, is intended to expand treatment infrastructure, fund recovery programs, and support overdose prevention at the state and local level.
People currently seeking rehab for opioid use disorder should know that medication-assisted treatment (MAT), using FDA-approved medications like buprenorphine or methadone alongside counseling, remains the evidence-based standard of care.
Insurance coverage for MAT has also expanded significantly under federal parity laws, meaning many rehab centers now offer these therapies at reduced or no cost depending on your plan.
Finding the Right Rehab
This settlement closes a chapter, but the opioid crisis is ongoing and hundreds of thousands of Americans still need access to quality addiction treatment every year.
If you or someone you love is struggling with opioid use, now is the time to explore treatment options and understand what your insurance covers.
- Compare accredited rehab centers specializing in opioid use disorder in your area
- Ask facilities about medication-assisted treatment (MAT) availability
- Verify that a program is licensed and uses evidence-based approaches
- Understand your insurance coverage for inpatient and outpatient rehab
Rehab.com’s directory lists thousands of rehab centers nationwide. Call
800-985-8516
( 
Sponsored Helpline )
to speak with a treatment advisor today.
